Bharat Biotech
About
India's second biggest vaccines company
- Hyderabad,Andhra Pradesh,India
- 501 - 1000
- http://www.bharatbiotech.com
Details
- Last Funding Type
- Private Equity（PE）
- Industries
- Biotechnology
- Founded date
- Jan 1, 1996
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Bharat Biotech International Limited, a biotechnology company, engages in the research, development, and manufacture of vaccines and biotherapeutics. Its products include Revac-B+, a recombinant hepatitis-B vaccine; TYPBAR, a vi polysaccharide typhoid vaccine; BIOPOLIO, a poliomyelitis vaccine; INDIRAB, a rabies vaccine; Revac-Bmcf, a thiomersal free recombinant hepatitis-B vaccine; TEVAC, a tetanus vaccine; Scorgen, a scorpion venom anti-serum; and BioHib, a haemophilus influenza type b vaccine
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 3, 2020 | Grant | $14.10M | 1 |
Coalition for Epidemic Preparedness Innovations
|
— | Detail |
| Jan 1, 2019 | Series Unknown | — | 1 |
Subhkam Ventures
|
— | Detail |
| Dec 16, 2016 | Private Equity（PE） | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Coalition for Epidemic Preparedness Innovations
|
Yes | Grant |
|
Subhkam Ventures
|
Yes | Series Unknown |
The Carlyle Group
|
— | Private Equity（PE） |
Employee Profiles
Acquisition
Bharat Biotech has acquired 1 organizations. Their most recent acquisition was Chiron Behring Vaccines on Feb 18, 2019. They acquired Chiron Behring Vaccines for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Feb 18, 2019
|
Biotechnology | acquisition | — | Detail |
